Targeting Mitochondria in Cardiovascular Diseases

医学 药理学 线粒体 背景(考古学) 雷诺嗪 生物信息学 生物 细胞生物学 古生物学
作者
Filomena Silva,Rui F. Simões,Renata Couto,Paulo J. Oliveira
出处
期刊:Current Pharmaceutical Design [Bentham Science Publishers]
卷期号:22 (37): 5698-5717 被引量:33
标识
DOI:10.2174/1381612822666160822150243
摘要

Cardiovascular diseases (CVDs) are one of the main factors responsible for human morbidity and mortality. Since mitochondria play a critical role in the regulation of cardiac tissue homeostasis, this organelle is a critical target for the protective effects of several pharmaceuticals. Although specific mitochondria-targeted antioxidants and some pharmacological agents are described as potential cardioprotective agents, there are still a few effective mitochondrial therapies for the treatment of CVDs. Agents which have potential cardioprotective effects by directly targeting mitochondria in vitro and in vivo are still in pre-clinical or clinical trials, hence their widespread use in the clinic is still far. Also, some of these agents have a decreased bioavailability or show some intrinsic toxicity, which also limits their working mitochondrial concentrations.By initially using PubMed specific queries for literature search, we review here cardiac mitochondrial effects of specific targeted and non-targeted antioxidants and pharmacological agents, including MitoE, MitoQ, MitoSNO, Mito-TEMPOL, SkQ1, SkQR1, carvedilol, trimetazidine, ranolazine, diazoxide and propofol.The present review emphasizes new mitochondrial-targeting strategies which have emerged to address difficulties arising from current approaches. We also describe the strengths and weaknesses of these cardioprotective approaches.Although effective therapies to target mitochondria in the context of CVDs are not under widespread clinical use, the new strategies proposed constitute a real promise for the development of therapies which may effectively prevent CVDs in the near future.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
PDF的下载单位、IP信息已删除 (2025-6-4)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
自由的鹏涛完成签到,获得积分20
3秒前
4秒前
在水一方应助Nayvue采纳,获得10
4秒前
7秒前
Ryan完成签到,获得积分10
8秒前
General完成签到 ,获得积分10
8秒前
谦让汝燕完成签到,获得积分10
10秒前
wellyou完成签到,获得积分10
11秒前
mint完成签到,获得积分10
13秒前
afli完成签到 ,获得积分0
16秒前
17秒前
Yy完成签到 ,获得积分10
20秒前
Nayvue发布了新的文献求助10
22秒前
feng完成签到,获得积分10
22秒前
淡淡的小蘑菇完成签到 ,获得积分10
25秒前
G_Serron完成签到,获得积分10
26秒前
swordshine完成签到,获得积分10
26秒前
Anonymous完成签到,获得积分10
30秒前
medzhou完成签到,获得积分10
34秒前
儒雅的千秋完成签到,获得积分10
42秒前
普鲁卡因发布了新的文献求助10
45秒前
小雯完成签到,获得积分10
46秒前
搞怪梦寒完成签到,获得积分20
47秒前
喵了个咪完成签到 ,获得积分10
48秒前
mc完成签到 ,获得积分10
50秒前
量子星尘发布了新的文献求助10
53秒前
54秒前
54秒前
虚幻谷波完成签到,获得积分10
56秒前
ruochenzu发布了新的文献求助10
59秒前
小马甲应助搞怪梦寒采纳,获得10
1分钟前
firewood完成签到 ,获得积分10
1分钟前
天天快乐应助普鲁卡因采纳,获得10
1分钟前
orixero应助NXK采纳,获得10
1分钟前
bjr完成签到 ,获得积分10
1分钟前
研友_LwlAgn完成签到,获得积分10
1分钟前
陈昊完成签到,获得积分10
1分钟前
1分钟前
tian发布了新的文献求助10
1分钟前
1分钟前
高分求助中
【提示信息,请勿应助】关于scihub 10000
Les Mantodea de Guyane: Insecta, Polyneoptera [The Mantids of French Guiana] 3000
徐淮辽南地区新元古代叠层石及生物地层 3000
The Mother of All Tableaux: Order, Equivalence, and Geometry in the Large-scale Structure of Optimality Theory 3000
Handbook of Industrial Diamonds.Vol2 1100
Global Eyelash Assessment scale (GEA) 1000
Picture Books with Same-sex Parented Families: Unintentional Censorship 550
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 遗传学 基因 物理化学 催化作用 冶金 细胞生物学 免疫学
热门帖子
关注 科研通微信公众号,转发送积分 4038128
求助须知:如何正确求助?哪些是违规求助? 3575831
关于积分的说明 11373827
捐赠科研通 3305610
什么是DOI,文献DOI怎么找? 1819255
邀请新用户注册赠送积分活动 892655
科研通“疑难数据库(出版商)”最低求助积分说明 815022